DDIT3 and Hyperglycemia: In conclusion, this study systemically revealed that diabetes-associated hyperglycemia markedly deteriorated liver IR damage via activation of the ER stress-ATF6-CHOP signaling pathway, which subsequently inhibited β-catenin signaling and promoted TLR4-mediated inflammatory responses (Supporting Fig. S3).